| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Corporation for Production and Research of Laboratory Primates, Tsukuba, Ibaraki, Japan (SN, SO, FO, KF), Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba, Ibaraki, Japan (NA, TS, KT), and the Department of Veterinary Medicine, College of Bioscience, Nihon University, Fujisawa, Kanagawa, Japan (HK)
Abstract
An aged male vervet monkey showed severe cardiac arrhythmia for more than 3 years. A multifocal amyloid consisting of transthyretin was deposited in all areas of the heart wall, especially in the extracellular stroma among muscle fibers and external tunica of arterioles. Moreover, the amyloid was deposited in the stroma and arterioles of other systemic organs except the liver and spleen. These characteristics are consistent with senile systemic amyloidosis in humans. A second amyloid consisting of amyloid β protein was in senile plaques and cerebral amyloid angiopathy in the cerebral cortex. A third amyloid consisting of islet amyloid polypeptide was deposited in islets of the pancreas. Apolipoprotein E and amyloid P component colocalized with the 3 amyloids. Thus, 3 different aging-related amyloids were found in an aged vervet monkey. In particular, to our knowledge, this is the first report on spontaneous transthyretin amyloidosis in animals.
Key words: Amyloidosis; amyloid β protein; IAPP; transthyretin.
Amyloid is a degenerative protein that exhibits common biochemical and morphologic characteristics, such as 1) birefringence under polarizing microscope, 2) abundant β pleated–sheets in the secondary structure of the proteins, and 3) nonbranching and nonparallel straight fibrils (8–10 nm in diameter) under electron microscope.13 However, each amyloid consists of different precursor proteins.13 Furthermore, amyloidosis may develop secondary to various conditions, such as inflammation, aging, and certain neoplasms. Transthyretin (TTR), amyloid β protein (Aβ), and islet amyloid polypeptide (IAPP) amyloidoses are well known as major aging-related amyloidoses.15 Among these amyloids, senile systemic amyloidosis (SSA), which is characterized by the deposition of amyloid fibrils containing TTR, is well known in aged humans but not in animals. In SSA, first small amyloid deposits, mainly in the heart, occur without obvious symptoms. However, in some case, massive amyloid deposits result in heart failure, eventually leading to death.15
In nonhuman primates, limited literature on amyloidosis is available. However, cerebral Aβ and islet amylin amyloidoses have been investigated in nonhuman primates as models for Alzheimer's disease and diabetes mellitus, respectively.7,10 In the vervet monkey, there has only been one report on cerebral Aβ deposition preventable by Aβ vaccination,4 whereas no study has been conducted for other types of amyloidoses.
A male vervet monkey (Cercopithecus aethiops), assumed to be 29 years old, showed severe cardiac arrhythmia for more than 3 years and bradycardia at the later stage of the 3 years, which were detected by 4-leads electrocardiography. Premature ventricular contractions (PVCs) were monitored by 24-hour Holter electrocardiography. The frequency of PVCs gradually became severe (3,000 PVCs per day) during the 3 years. Moreover, dilatation of the right ventricle was detected by ultrasound and X-ray examinations. However, for the left ventricle, no obvious disorders, such as reduced left ventricular ejection fractions, were observed by echocardiography. Symptoms associated with Alzheimer's disease and diabetes mellitus were not observed in the present case. Finally, the monkey was euthanized because of poor prognosis due to severe depression and anorexia.
At necropsy, collected tissues were fixed in 10% buffered formalin, embedded in paraffin, and sectioned at 4 µm. The deparaffinized sections were stained with hematoxylin and eosin. Some sections were stained with Congo red and direct fast scarlet (DFS; Muto, Tokyo, Japan) with or without potassium permanganate (PPM). Positive reactions for Congo red and DFS were confirmed by apple green birefringence under polarizing microscope. Furthermore, some deparaffinized sections were immunostained using rabbit polyclonal antibodies against Aβ 1–42 (Aβ42; Chemicon, Temecula, CA; 1:100), amyloid P component (AP; DAKO, Glostrup, Denmark; 1:300), apolipoprotein E (apoE; DAKO; 1:1000), calcitonin (IBL, Takasaki, Japan; 1:400), kappa light chains (
AL; DAKO; 1:20000), lambda light chains (
AL; DAKO; 1:40000), and TTR (DAKO; 1:100) and using mouse monoclonal antibodies against amyloid A (AA; Novocastra, Newcastle, UK; 1:100) and IAPP (Serotec, Raleigh, NC; 1:100). Sections immunostained for Aβ42 were pretreated with 99% formic acid for 10 minutes. The remaining immunostains used pretreatment with citrate buffer (pH 6.0, 121°C, 10 min). These sections were further reacted with horseradish peroxidase-conjugated secondary mouse and rabbit immunoglobulins (EnVision+ System, DAKO) and then visualized with 3,3'-diaminobenzidine tetrahydrochloride (DAB).
At necropsy, the heart revealed slight dilatation of both ventricles with thinning of the right ventricular free wall. The surface of the heart was reddish brown with pale white spots (Fig. 1). The brain and pancreas showed slight atrophy.
|
|
|
The second type of hyaline deposit, such as neuritic senile plaques (SPs), was observed in the cerebral cortices. DFS and Congo red detected not only some neuritic SPs but also deposits consistent with cerebral amyloid angiopathy (CAA) (Table 1), as found previously in vervet and cynomolgus monkeys.4,5 This type of amyloid was resistant to PPM and revealed apple green birefringence under polarizing microscope (data not shown). Furthermore, SPs and CAA were immunohistochemically labeled using antibodies against Aβ42, apoE, and AP (Fig. 6, Table 1). The intensity of immunoreactivity was stronger with Aβ42 and apoE than with AP. Diffuse plaques, found previously in cynomolgus monkeys,5 were not found in the present case. This amyloid derived from Aβ was not deposited in the other organs (Table 1).
The third type of hyaline deposit was found in the expanded stromal areas of islets of the pancreas. This was positive for Congo red and DFS and resistant to PPM (Table 1) and showed apple green birefringence under polarizing microscope (data not shown). This amyloid was immunohistochemically positive for antibodies against IAPP, apoE, and AP (Fig. 7, Table 1). The intensity of immunoreactivity was stronger with IAPP and apoE than with AP. The islets, where abundant amyloid was deposited, had a reduced number of islet cells. This IAPP-derived amyloid was not detected from any other organ (Table 1).
Finally, all the 3 types of hyaline deposits were immunohistochemically negative for antibodies against AA, calcitonin, AL, and AL (Table 1).
Although there is no information about amino acid sequences of TTR, Aβ, and IAPP in vervet monkeys, the sequences in human are 93.1%, 100%, and 94.6% homology (BAC20609 and XP_001098180),11 respectively, against those in macaque monkeys and vervet monkeys, who belong taxonomically to Cercopithecus. Antibodies to TTR and Aβ used in the present study have reacted with each amyloid lesion, that is, cardiac amyloid in SSA and SPs in AD, consisting of intact mature amyloid in human.8,12 The immunoreactivities of humans were absolutely corresponding to that of this vervet monkey. According to these facts, we assumed that these antibodies recognized suitable TTR and Aβ amyloid lesions in vervet monkeys, as well as humans. On the other hand, as for IAPP, detail immunohistochemical information of an antibody to IAPP 7–17 residue used in this study has not been described, while similar antibodies to IAPP 8–17 residue reacted well with intact islet amyloid in humans and cats.6 The immunoreactivity of an antibody to IAPP 8–17 was consistent with that of an antibody to IAPP 7–17. Those IAPP residues are conserved between various mammalian species, and IAPP 8–20 is known as the second major constituent of islet amyloid.5 Therefore, we assumed that the antibody to IAPP used in this study reacted precisely with intact islet amyloid of this monkey species.
SSA is one of the common systemic amyloidoses in humans, occurring in 25% of people who are older than 80 years.15 SSA has been previously called cardiac amyloidosis because it shows cardiac symptoms, such as heart failure and/or arrhythmia, due to severe amyloid deposition in the heart.15 As for histopathologic characteristics of SSA in humans, the organ most severely affected by amyloid deposition is the heart, while deposition is also found in the other systemic organs. On the other hand, there are few amyloid deposits in the liver, spleen, and kidney, except the renal pelvis, which are frequent organs for other types of systemic amyloidoses, such as AA or AL amyloidosis.15 These histopathologic features in humans are consistent with those in the vervet monkey. Furthermore, clinical symptoms, such as arrhythmia, and biochemical aspects of the amyloid precursor, such as TTR and not AA or AL, in humans, correspond to the characteristics in the vervet monkey.14 Another manifestation of TTR amyloid deposition is familial or hereditary TTR amyloidosis, which is known as familial amyloid polyneuropathy (FAP).15 FAP patients with a variant TTR reveal onset of cardiac symptoms and severe systemic TTR amyloidosis usually the third decade of life, with deposits especially prominent in the heart and peripheral nervous system.13 Because there is no information for TTR amino acid sequence and its mutant in vervet monkeys, the hereditary aspect of TTR amyloidosis could not be considered in the present study. However, the clinical, histologic, and immunohistochemical features suggest that the monkey suffered from SSA and not FAP, because the monkey was very old (a 29-year-old monkey corresponds nearly to an 85-year-old human) and because amyloid was deposited exclusively in the heart rather than in the peripheral nerves.
Teng and colleagues14 reported that transgenic mice overexpressing human wild-type TTR gene revealed predominant deposits of TTR-positive and DFS-negative materials in the heart and kidney. This type of deposit is consistent with the deposits in the testes of the vervet monkey in this study. Namely, the deposits in TTR transgenic mice and this vervet monkey may be considered immature materials before amyloid fibril formation.14
Cerebral amyloidosis consisting of Aβ is an aging-related amyloidosis, although it occurs earlier and is significantly developed in Alzheimer's disease.6,8 SPs and CAA as histopathologic hallmarks in Alzheimer's disease also appear in aged nonhuman primates.7 SPs in cynomolgus monkeys are morphologically classified into neuritic and diffuse plaques; the neuritic plaques are more frequently observed than the diffuse ones, whereas CAA is more frequently found in capillaries than in meningeal arterioles.7 Findings of abundant neuritic plaques and predominant capillary CAA rather than meningeal CAA have been described previously, in the first study of SPs and CAA in a vervet monkey.4 The characteristics of SPs and CAA in the present study are consistent with the previous studies of cynomolgus monkeys.7
Islet amyloidosis consisting of IAPP often appears as one of the aging-related changes in aged primates including humans,3 while this amyloid deposition is accelerated in diabetes mellitus.13 Because the vervet monkey did not have any history for diabetes, possibilities are considered that the islet amyloid deposition in this monkey likely occurred as an aging-related change and that degrading insulin secretion in the absence of fasting hyperglycemia was associated with an increase of IAPP aggregation and the onset of islet amyloidosis.3 This type of amyloid deposition has been previously reported in various primate species, that is, humans and macaque monkeys.10,13 Morphologic and immunohistochemical characteristics of islet amyloidosis in vervet monkey are consistent with those in other primate species.10
ApoE and AP are often colocalized with various types of amyloid precursors, such as Aβ, prion protein, AA, and IAPP7,9,13 and accelerate in vitro fibril formation of the amyloids.1 Although in vitro data on the correlation between apoE and TTR have not been confirmed previously, the colocalization of apoE in the TTR amyloid portion suggests that TTR amyloid deposition might be accelerated by apoE and AP, as well as other types of amyloids.13 In summery, 3 different aging-related amyloidoses were found in an aged vervet monkey. TTR amyloidosis has only been reported in SAMP mice,2 while this is the first spontaneous case report on TTR amyloidosis in mammalian species, other than humans and experimental animals with a special genetic background.
Acknowledgement
The authors thank Ms. Chieko Ohno for her technical help.
References
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
